Opioid regulation of mu receptor internalisation: Relevance to the development of tolerance and dependence

CNS and Neurological Disorders - Drug Targets

Volumn 9, Issue 5, 2010, Pages 616-626

  Lopez Gimenez, Juan F ^a   Milligan, Graeme ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Dependence; Desensitization; Morphine; Receptor internalisation; Tolerance

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; OPIATE; OPIATE AGONIST;

ARTICLE; CELL FREE SYSTEM; DRUG ACTIVITY; DRUG TOLERANCE; ENDOCYTOSIS; HUMAN; INTERNALIZATION; NONHUMAN; OPIATE ADDICTION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

EID: 78649283111     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152710793361522     Document Type: Article

References (70)

1. Waldhoer, M.; Bartlett, S. E.; Whistler, J. L. Opioid receptors. Annu. Rev. Biochem., 2004, 73, 953-990
2. Matthes, H. W.; Maldonado, R.; Simonin, F.; Valverde, O.; Slowe, S.; Kitchen, I.; Befort, K.; Dierich, A.; Le Meur, M.; Dolle, P.; Tzavara, E.; Hanoune, J.; Roques, B. P.; Kieffer, B. L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature, 1996, 383(6603), 819-823
3. Nestler, E. J. Under siege: the brain on opiates. Neuron, 1996, 16(5), 897-900
4. Williams, J. T.; Christie, M. J.; Manzoni, O. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev., 2001, 81(1), 299-343
5. Christie, M. J. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br. J. Pharmacol., 2008, 154(2), 384-396
6. Ferguson, S. S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev., 2001, 53(1), 1-24
7. Luttrell, L. M.; Lefkowitz, R. J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci., 2002, 115(Pt 3), 455-465
8. Bailey, C. P.; Connor, M. Opioids: cellular mechanisms of tolerance and physical dependence. Curr. Opin. Pharmacol., 2005, 5(1), 60-68
9. Connor, M.; Osborne, P. B.; Christie, M. J. Mu-opioid receptor desensitization: is morphine different? Br. J. Pharmacol., 2004, 143(6), 685-696
10. Garzon, J.; Rodriguez-Munoz, M.; Sanchez-Blazquez, P. Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr. Drug Abuse Rev., 2008, 1(2), 222-238
11. Koch, T.; Hollt, V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol. Ther., 2008, 117(2), 199-206
12. Martini, L.; Whistler, J. L. The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr. Opin. Neurobiol., 2007, 17(5), 556-564
13. von Zastrow, M.; Svingos, A.; Haberstock-Debic, H.; Evans, C. Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs. Curr. Opin. Neurobiol., 2003, 13(3), 348-353
14. Arden, J. R.; Segredo, V.; Wang, Z.; Lameh, J.; Sadee, W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem., 1995, 65(4), 1636-1645
15. Keith, D. E.; Murray, S. R.; Zaki, P. A.; Chu, P. C.; Lissin, D. V.; Kang, L.; Evans, C. J.; von Zastrow, M. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem., 1996, 271(32), 19021-19024
16. Sternini, C.; Spann, M.; Anton, B.; Keith, D. E., Jr.; Bunnett, N. W.; von Zastrow, M.; Evans, C.; Brecha, N. C. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA, 1996, 93(17), 9241-9246
17. Segredo, V.; Burford, N. T.; Lameh, J.; Sadee, W. A constitutively internalizing and recycling mutant of the mu-opioid receptor. J. Neurochem., 1997, 68(6), 2395-2404
18. Keith, D. E.; Anton, B.; Murray, S. R.; Zaki, P. A.; Chu, P. C.; Lissin, D. V.; Monteillet-Agius, G.; Stewart, P. L.; Evans, C. J.; von Zastrow, M. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol., 1998, 53(3), 377-384
19. Bushell, T.; Endoh, T.; Simen, A. A.; Ren, D.; Bindokas, V. P.; Miller, R. J. Molecular components of tolerance to opiates in single hippocampal neurons. Mol. Pharmacol., 2002, 61(1), 55-64
20. Borgland, S. L.; Connor, M.; Osborne, P. B.; Furness, J. B.; Christie, M. J. Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of muopioid receptors. J. Biol. Chem., 2003, 278(21), 18776-18784
21. Alvarez, V. A.; Arttamangkul, S.; Dang, V.; Salem, A.; Whistler, J. L.; Von Zastrow, M.; Grandy, D. K.; Williams, J. T. mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization. J. Neurosci., 2002, 22(13), 5769-5776
22. Celver, J.; Xu, M.; Jin, W.; Lowe, J.; Chavkin, C. Distinct domains of the mu-opioid receptor control uncoupling and internalization. Mol. Pharmacol., 2004, 65(3), 528-537
23. Arttamangkul, S.; Torrecilla, M.; Kobayashi, K.; Okano, H.; Williams, J. T. Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J. Neurosci., 2006, 26(15), 4118-4125
24. Whistler, J. L.; Chuang, H. H.; Chu, P.; Jan, L. Y.; von Zastrow, M. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron, 1999, 23(4), 737-746
25. Afify, E. A.; Law, P. Y.; Riedl, M.; Elde, R.; Loh, H. H. Role of carboxyl terminus of mu-and delta-opioid receptor in agonistinduced down-regulation. Brain Res. Mol. Brain Res., 1998, 54(1), 24-34
26. Oldfield, S.; Braksator, E.; Rodriguez-Martin, I.; Bailey, C. P.; Donaldson, L. F.; Henderson, G.; Kelly, E. C-terminal splice variants of the mu-opioid receptor: existence, distribution and functional characteristics. J. Neurochem., 2008, 104(4), 937-945
27. Pasternak, G. W. Multiple opiate receptors: deja vu all over again. Neuropharmacology, 2004, 47(Suppl 1), 312-323
28. Choi, H. S.; Kim, C. S.; Hwang, C. K.; Song, K. Y.; Wang, W.; Qiu, Y.; Law, P. Y.; Wei, L. N.; Loh, H. H. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor. Biochem. Biophys. Res. Commun., 2006, 343(4), 1132-1140
29. Koch, T.; Schulz, S.; Schroder, H.; Wolf, R.; Raulf, E.; Hollt, V. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem., 1998, 273(22), 13652-13657
30. Koch, T.; Schulz, S.; Pfeiffer, M.; Klutzny, M.; Schroder, H.; Kahl, E.; Hollt, V. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem., 2001, 276(33), 31408-31414
31. El Kouhen, R.; Burd, A. L.; Erickson-Herbrandson, L. J.; Chang, C. Y.; Law, P. Y.; Loh, H. H. Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. J. Biol. Chem., 2001, 276(16), 12774-12780
32. Abbadie, C.; Pan, Y. X.; Pasternak, G. W. Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain. Neuroscience, 2004, 127(2), 419-430
33. Schulz, S.; Mayer, D.; Pfeiffer, M.; Stumm, R.; Koch, T.; Hollt, V. Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J., 2004, 23(16), 3282-3289
34. Milasta, S.; Evans, N. A.; Ormiston, L.; Wilson, S.; Lefkowitz, R. J.; Milligan, G. The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochem. J., 2005, 387(Pt 3), 573-584
35. Ravindranathan, A.; Joslyn, G.; Robertson, M.; Schuckit, M. A.; Whistler, J. L.; White, R. L. Functional characterization of human variants of the mu-opioid receptor gene. Proc. Natl. Acad. Sci. USA, 2009, 106(26), 10811-10816
36. Premont, R. T.; Gainetdinov, R. R. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol., 2007, 69, 511-534
37. Pierce, K. L.; Lefkowitz, R. J. Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat. Rev. Neurosci., 2001, 2(10), 727-733
38. Whistler, J. L.; von Zastrow, M. Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. USA, 1998, 95(17), 9914-9919
39. Zhang, J.; Ferguson, S. S.; Barak, L. S.; Bodduluri, S. R.; Laporte, S. A.; Law, P. Y.; Caron, M. G. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA, 1998, 95(12), 7157-7162
40. Schulz, R.; Wehmeyer, A.; Murphy, J.; Schulz, K. Phosducin, beta-arrestin and opioid receptor migration. Eur. J. Pharmacol., 1999, 375(1-3), 349-357
41. Minnis, J. G.; Patierno, S.; Kohlmeier, S. E.; Brecha, N. C.; Tonini, M.; Sternini, C. Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons. Neuroscience, 2003, 119(1), 33-42
42. Groer, C. E.; Tidgewell, K.; Moyer, R. A.; Harding, W. W.; Rothman, R. B.; Prisinzano, T. E.; Bohn, L. M. An opioid agonist that does not induce micro-opioid receptor--arrestin interactions or receptor internalization. Mol. Pharmacol., 2007, 71(2), 549-557
43. Haberstock-Debic, H.; Wein, M.; Barrot, M.; Colago, E. E.; Rahman, Z.; Neve, R. L.; Pickel, V. M.; Nestler, E. J.; von Zastrow, M.; Svingos, A. L. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J. Neurosci., 2003, 23(10), 4324-4332
44. Haberstock-Debic, H.; Kim, K. A.; Yu, Y. J.; von Zastrow, M. Morphine promotes rapid, arrestin-dependent endocytosis of muopioid receptors in striatal neurons. J. Neurosci., 2005, 25(34), 7847-7857
45. Zachariou, V.; Georgescu, D.; Sanchez, N.; Rahman, Z.; DiLeone, R.; Berton, O.; Neve, R. L.; Sim-Selley, L. J.; Selley, D. E.; Gold, S. J.; Nestler, E. J. Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. USA, 2003, 100(23), 13656-13661
46. Garzon, J.; Rodriguez-Munoz, M.; Lopez-Fando, A.; Sanchez-Blazquez, P. Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization. J. Biol. Chem., 2005, 280(10), 8951-8960
47. Psifogeorgou, K.; Papakosta, P.; Russo, S. J.; Neve, R. L.; Kardassis, D.; Gold, S. J.; Zachariou, V. RGS9-2 is a negative modulator of mu-opioid receptor function. J. Neurochem., 2007, 103(2), 617-625
48. Rodriguez-Munoz, M.; de la Torre-Madrid, E.; Gaitan, G.; Sanchez-Blazquez, P.; Garzon, J. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. Cell Signal., 2007, 19(12), 2558-2571
49. Koch, T.; Brandenburg, L. O.; Schulz, S.; Liang, Y.; Klein, J.; Hollt, V. ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis. J. Biol. Chem., 2003, 278(11), 9979-9985
50. He, L.; Fong, J.; von Zastrow, M.; Whistler, J. L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell, 2002, 108(2), 271-282
51. Schroder, H.; Wu, D. F.; Seifert, A.; Rankovic, M.; Schulz, S.; Hollt, V.; Koch, T. Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor. Neuropharmacology, 2009, 56(4), 768-778
52. Milligan, G.; Smith, N. J. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol. Sci., 2007, 28(12), 615-620
53. Lopez-Gimenez, J. F.; Vilaro, M. T.; Milligan, G. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation. Mol. Pharmacol., 2008, 74(5), 1278-1291
54. Yu, Y. J.; Arttamangkul, S.; Evans, C. J.; Williams, J. T.; von Zastrow, M. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons. J. Neurosci., 2009, 29(1), 222-233
55. Watts, V. J.; Neve, K. A. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol. Ther., 2005, 106(3), 405-421
56. Finn, A. K.; Whistler, J. L. Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron, 2001, 32(5), 829-839
57. Zhao, H.; Loh, H. H.; Law, P. Y. Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol. Pharmacol., 2006, 69(4), 1421-1432
58. Xu, H.; Partilla, J. S.; Wang, X.; Rutherford, J. M.; Tidgewell, K.; Prisinzano, T. E.; Bohn, L. M.; Rothman, R. B. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) muopioid agonists on cellular markers related to opioid tolerance and dependence. Synapse, 2007, 61(3), 166-175
59. Grecksch, G.; Bartzsch, K.; Widera, A.; Becker, A.; Hollt, V.; Koch, T. Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology (Berl.), 2006, 186(2), 177-184
60. He, L.; Whistler, J. L. An opiate cocktail that reduces morphine tolerance and dependence. Curr. Biol., 2005, 15(11), 1028-1033
61. Hashimoto, T.; Saito, Y.; Yamada, K.; Hara, N.; Kirihara, Y.; Tsuchiya, M. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats. Anesthesiology, 2006, 105(3), 574-580
62. Kim, J. A.; Bartlett, S.; He, L.; Nielsen, C. K.; Chang, A. M.; Kharazia, V.; Waldhoer, M.; Ou, C. J.; Taylor, S.; Ferwerda, M.; Cado, D.; Whistler, J. L. Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr. Biol., 2008, 18(2), 129-135
63. He, L.; Kim, J. A.; Whistler, J. L. Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor. FASEB J., 2009, 23(12), 4327-4334
64. Bohn, L. M.; Lefkowitz, R. J.; Gainetdinov, R. R.; Peppel, K.; Caron, M. G.; Lin, F. T. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science, 1999, 286(5449), 2495-2498
65. Bohn, L. M.; Gainetdinov, R. R.; Lin, F. T.; Lefkowitz, R. J.; Caron, M. G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature, 2000, 408(6813), 720-723
66. Raehal, K. M.; Walker, J. K.; Bohn, L. M. Morphine side effects in beta-arrestin 2 knockout mice. J. Pharmacol. Exp. Ther., 2005, 314(3), 1195-1201
67. Terman, G. W.; Jin, W.; Cheong, Y. P.; Lowe, J.; Caron, M. G.; Lefkowitz, R. J.; Chavkin, C. G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br. J. Pharmacol., 2004, 141(1), 55-64
68. Raehal, K. M.; Schmid, C. L.; Medvedev, I. O.; Gainetdinov, R. R.; Premont, R. T.; Bohn, L. M. Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6. Drug Alcohol Depend., 2009, 104(3), 187-196
69. Grillet, N.; Pattyn, A.; Contet, C.; Kieffer, B. L.; Goridis, C.; Brunet, J. F. Generation and characterization of Rgs4 mutant mice. Mol. Cell Biol., 2005, 25(10), 4221-4228
70. Han, M. H.; Renthal, W.; Ring, R. H.; Rahman, Z.; Psifogeorgou, K.; Howland, D.; Birnbaum, S.; Young, K.; Neve, R.; Nestler, E. J.; Zachariou, V. Brain Region Specific Actions of Regulator of G Protein Signaling 4 Oppose Morphine Reward and Dependence but Promote Analgesia. Biol. Psychiatry, 2010, 67(8), 761-769.